• IDC
  • About IDC
  • IDC Media Center
  • Current: 2 out of 5 Life Sciences Organizations in Asia/Pacific Adopt GenAI Digital Transformation Tools for DX Initiatives, Says IDC Report
Press FAQ

Publication date: 28 Sep 2023

2 out of 5 Life Sciences Organizations in Asia/Pacific Adopt GenAI Digital Transformation Tools for DX Initiatives, Says IDC Report

Contact

For more information, contact:

Majority of Life Sciences (LS) Organizations See Innovation as Top Business Driver

SINGAPORE, September 28, 2023 – According to a recent IDC report, 2023 Life Sciences Digital Transformation Survey: Asia/Pacific (Including Japan) Perspectives, majority of the Life Sciences organizations in Asia/Pacific identified innovation as the top business driver moving forward. In line with this innovation–driven approach, two out of five said they are using generative AI tools for digital transformation (DX) initiatives.

This IDC report shows that the Life Sciences (LS) industry has undergone major DX in Asia/Pacific at an accelerated pace in the past two years. Business leaders within Asia/Pacific LS organizations are prioritizing prescription digital therapeutics, digital patient engagement, drug safety & discovery, and decentralized clinical trials (DCTs), as part of their DX initiatives. The report also reveals that DX strategies among Asia/Pacific LS organizations are being largely driven by IT but increasingly becoming a collaborative process between IT and LOB (line-of-business) teams.

Highlights of the report include:

  • Over 78% of LS organizations in Asia/Pacific are undergoing DX.
  • Around 46% of the Asia/Pacific respondents said they have increased DX spending in 2023 compared to 2022.
  • To implement DX, LS organizations in Asia/Pacific prioritize emerging technologies, particularly IoT, data security, and cloud technologies.
  • Data security and privacy are the top DX challenge for Asia/Pacific LS organizations.

"Over three quarters of Asia/Pacific's Life Sciences organizations are embracing digital transformation, with GenAI propelling innovations like precision drugs, improved workflows, and enhanced patient experiences. As we advance, the emphasis will grow on cybersecurity and KPI-driven partnerships to sustain this momentum," says Manoj Vallikkat, Senior Research Manager at IDC Asia/Pacific Healthcare Insights.

For more information on this IDC document, please contact Louise Francis at lfrancis@idc.com or Manoj Vallikkat at mvallikkat@idc.com. For media inquiries, please contact Miguel Carreon at mcarreon@idc.com or Michael de la Cruz at mdelacruz@idc.com.

*Asia/Pacific including Japan

-Ends-

IDC Health Insights

IDC Health Insights assists health businesses and IT leaders, in making more effective technology decision by providing insightful fact-based research and consulting services. Our global research analyzes and advises on business and technology issues facing the payer, provider and life sciences industries. For more information, please visit www.idc.com/insights/health .

About IDC

International Data Corporation (IDC) is the premier global provider of market intelligence, advisory services, and events for the information technology, telecommunications, and consumer technology markets. With more than 1,300 analysts worldwide, IDC offers global, regional, and local expertise on technology and industry opportunities and trends in over 110 countries. IDC's analysis and insight helps IT professionals, business executives, and the investment community to make fact-based technology decisions and to achieve their key business objectives. Founded in 1964, IDC is a wholly-owned subsidiary of International Data Group (IDG), the world's leading tech media, data and marketing services company. To learn more about IDC, please visit www.idc.com. Follow IDC on Twitter at @IDCAP and LinkedIn. Subscribe to the IDC Blog for industry news and insights.



Coverage


Regions Covered

Asia Pacific


Topics Covered